Strain identifier

BacDive ID: 135644

Type strain: No

Species: Bifidobacterium longum

Strain Designation: S3

Strain history: CIP <- 1964, Lab. Ident. Inst. Pasteur, Paris, France <- M. Sebald, Inst. Pasteur, Paris, France <- H. Werner <- G. Reuter: strain S3

NCBI tax ID(s): 216816 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 8.1 (current version):
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 8.1 (current version)

General

@ref: 34822

BacDive-ID: 135644

keywords: 16S sequence, Bacteria, mesophilic

description: Bifidobacterium longum S3 is a mesophilic bacterium that was isolated from Intestine of infant.

NCBI tax id

  • NCBI tax id: 216816
  • Matching level: species

strain history

@refhistory
67770T. Mitsuoka IV-54 <-- G. Reuter S3 (Variant b).
34822CIP <- 1964, Lab. Ident. Inst. Pasteur, Paris, France <- M. Sebald, Inst. Pasteur, Paris, France <- H. Werner <- G. Reuter: strain S3

doi: 10.13145/bacdive135644.20230509.8.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/actinomycetota
  • domain: Bacteria
  • phylum: Actinomycetota
  • class: Actinomycetes
  • order: Bifidobacteriales
  • family: Bifidobacteriaceae
  • genus: Bifidobacterium
  • species: Bifidobacterium longum
  • full scientific name: Bifidobacterium longum Reuter 1963 (Approved Lists 1980)

@ref: 34822

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Bifidobacteriales

family: Bifidobacteriaceae

genus: Bifidobacterium

species: Bifidobacterium longum

strain designation: S3

type strain: no

Culture and growth conditions

culture medium

@refnamegrowthcompositionlink
34822MEDIUM 20 - for Anaerobic bacteriayesAgar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml)
34822CIP Medium 20yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=20

culture temp

@refgrowthtypetemperaturerange
34822positivegrowth37mesophilic
67770positivegrowth37mesophilic

Isolation, sampling and environmental information

isolation

@refsample type
67770Intestine of infant
34822Human, Infant, intestine

Safety information

risk assessment

  • @ref: 34822
  • biosafety level: 1
  • biosafety level comment: Risk group (French classification)

Sequence information

16S sequences

  • @ref: 67770
  • description: Bifidobacterium longum ATCC 15708 16S ribosomal RNA
  • accession: U10152
  • length: 1455
  • database: ena
  • NCBI tax ID: 216816

External links

@ref: 34822

culture collection no.: CIP 64.63, ATCC 15708, JCM 7054, BCRC 14634, LMG 10498

straininfo link

  • @ref: 92961
  • straininfo: 1253

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Metabolism8792277Improvement of lactose digestion in humans by ingestion of unfermented milk containing Bifidobacterium longum.Jiang T, Mustapha A, Savaiano DAJ Dairy Sci10.3168/jds.S0022-0302(96)76422-61996Adult, Animals, Bifidobacterium/*metabolism, Breath Tests, *Digestion, Double-Blind Method, Female, Fermentation, Glucose/metabolism, Humans, Hydrogen/metabolism, Lactose/*metabolism, Lactose Intolerance/metabolism/*therapy, Male, Milk/*microbiology, beta-Galactosidase/metabolismPathogenicity
Pathogenicity8872711Growth characteristics of bifidobacteria in infant formulas.Dubey UK, Mistry VVJ Dairy Sci10.3168/jds.S0022-0302(96)76468-81996Acetic Acid/metabolism, Animals, Bifidobacterium/cytology/*growth & development, Buffers, Caseins, Fats/analysis, Humans, Hydrogen-Ion Concentration, Infant Food/analysis/*microbiology, Infant, Newborn, Kinetics, Lactic Acid/biosynthesis, Milk, Protein Hydrolysates, Proteins/analysis, SoybeansEnzymology
Pathogenicity8872712Effect of bifidogenic factors on growth characteristics of bifidobacteria in infant formulas.Dubey UK, Mistry VVJ Dairy Sci10.3168/jds.S0022-0302(96)76469-X1996Acetic Acid/metabolism, Bifidobacterium/*drug effects/*growth & development, Caseins, Colony Count, Microbial, Fructose/*pharmacology, Humans, Hydrogen-Ion Concentration, Infant, Infant Food/analysis/*microbiology, Lactic Acid/biosynthesis, Lactulose/*pharmacology, Oligosaccharides/*pharmacology, Protein Hydrolysates, SoybeansMetabolism
Pathogenicity11003222Viability of microencapsulated bifidobacteria in set yogurt during refrigerated storage.Adhikari K, Mustapha A, Grun IU, Fernando LJ Dairy Sci10.3168/jds.S0022-0302(00)75070-32000Acetic Acid/analysis, Bifidobacterium/*growth & development, Carrageenan, Colony Count, Microbial, Consumer Behavior, Drug Compounding, *Food Preservation, Humans, Hydrogen-Ion Concentration, Lactic Acid/analysis, *Probiotics, *Refrigeration, Taste, Time Factors, Yogurt/*microbiology/standards
Metabolism11007114Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356.Lin MY, Chang FJDig Dis Sci10.1023/a:10055773306952000Bifidobacterium/*physiology, Free Radical Scavengers, Intestines/*microbiology, Lactobacillus acidophilus/*physiology, Linoleic Acids/metabolism, Lipid Peroxidation, Nitroquinolines/metabolism, Oxidation-Reduction
Enzymology14762068Purification and characterization of three different types of bile salt hydrolases from Bifidobacterium strains.Kim GB, Yi SH, Lee BHJ Dairy Sci10.3168/jds.S0022-0302(04)73164-12004Amidohydrolases/chemistry/*isolation & purification/metabolism, Amino Acid Sequence, Bifidobacterium/*enzymology, Chromatography, Ion Exchange, Electrophoresis, Polyacrylamide Gel, Isoelectric Point, Substrate SpecificityPhylogeny
20832691The determination of viable counts in probiotic cultures microencapsulated by spray-coating.Champagne CP, Raymond Y, Tompkins TAFood Microbiol10.1016/j.fm.2010.07.0172010Bifidobacterium/chemistry/*growth & development, Colony Count, Microbial/*methods, *Drug Compounding, Freeze Drying, Lactobacillus rhamnosus/chemistry/*growth & development, *Microbial Viability, Particle Size, Probiotics/*chemistry
Pathogenicity20884069Exopolysaccharide activities from probiotic bifidobacterium: Immunomodulatory effects (on J774A.1 macrophages) and antimicrobial properties.Wu MH, Pan TM, Wu YJ, Chang SJ, Chang MS, Hu CYInt J Food Microbiol10.1016/j.ijfoodmicro.2010.09.0032010Animals, Anti-Infective Agents/immunology/metabolism/*pharmacology, Bifidobacterium/*chemistry/immunology, Cell Line, Cell Proliferation/drug effects, Gene Expression Regulation/drug effects, Immunologic Factors/*pharmacology, Interleukin-10/immunology, Lipopolysaccharides/pharmacology, Macrophages/*drug effects/immunology, Mice, Polysaccharides, Bacterial/isolation & purification/*pharmacology, *Probiotics, Tumor Necrosis Factor-alpha/immunologyMetabolism
Metabolism24013960Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes.Yu ZT, Chen C, Newburg DSGlycobiology10.1093/glycob/cwt0652013Bacterial Proteins/metabolism, Bacteroides/growth & development/isolation & purification/metabolism, Bifidobacterium/growth & development/isolation & purification/metabolism, Clostridium/growth & development/isolation & purification/metabolism, Culture Media, Enterococcus faecalis/growth & development/isolation & purification/metabolism, Escherichia coli K12/growth & development/isolation & purification/metabolism, Fucose/metabolism, Gastrointestinal Tract/*microbiology, Glycosylation, Humans, Hydrogen-Ion Concentration, Lactobacillus delbrueckii/growth & development/isolation & purification/metabolism, *Microbiota, Milk, Human/*metabolism, Oligosaccharides/*metabolism, Sialic Acids/metabolism, Streptococcus thermophilus/growth & development/isolation & purification/metabolism, alpha-L-Fucosidase/metabolismPhylogeny
Phylogeny29116036Bifidobacterium callitrichidarum sp. nov. from the faeces of the emperor tamarin (Saguinus imperator).Modesto M, Michelini S, Sansosti MC, De Filippo C, Cavalieri D, Qvirist L, Andlid T, Spiezio C, Sandri C, Pascarelli S, Sgorbati B, Mattarelli PInt J Syst Evol Microbiol10.1099/ijsem.0.0024722017Aldehyde-Lyases/chemistry, Animals, Bacterial Typing Techniques, Base Composition, Bifidobacterium/*classification/genetics/isolation & purification, DNA, Bacterial/genetics, Fatty Acids/chemistry, Feces/microbiology, Multilocus Sequence Typing, Peptidoglycan/chemistry, *Phylogeny, RNA, Ribosomal, 16S/genetics, Saguinus/*microbiology, Sequence Analysis, DNATranscriptome
Phylogeny30150092Bifidobacterium primatium sp. nov., Bifidobacterium scaligerum sp. nov., Bifidobacterium felsineum sp. nov. and Bifidobacterium simiarum sp. nov.: Four novel taxa isolated from the faeces of the cotton top tamarin (Saguinus oedipus) and the emperor tamarin (Saguinus imperator).Modesto M, Puglisi E, Bonetti A, Michelini S, Spiezio C, Sandri C, Sgorbati B, Morelli L, Mattarelli PSyst Appl Microbiol10.1016/j.syapm.2018.07.0052018Aldehyde-Lyases/genetics, Animals, Animals, Zoo/microbiology, Bacterial Typing Techniques, Bifidobacterium/*classification/genetics/isolation & purification, DNA, Bacterial/genetics, Feces/*microbiology, Italy, Peptidoglycan/chemistry, *Phylogeny, RNA, Ribosomal, 16S/genetics, Saguinus/*microbiology, Sequence Analysis, DNATranscriptome
32380678Lyophilized Probiotic Lactic Acid Bacteria Viability in Potato Chips and Its Impact on Oil Oxidation.Mostafa HFoods10.3390/foods90505862020

Reference

@idauthorstitledoi/urlcatalogue
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ10.1099/ijsem.0.004332
34822Curators of the CIPhttps://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2064.63Collection of Institut Pasteur (CIP 64.63)
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
92961Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.StrainInfo: A central database for resolving microbial strain identifiers10.60712/SI-ID1253.1